AgomAb Therapeutics NV’s USD 74 Million Series B Financing round

Deloitte Legal assisted AgomAb Therapeutics NV on the deal.AgomAb Therapeutics NV completed the raise of a USD 74 million Series B financing round to fund a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here